Media Center
Press Releases

Press Releases

15 Sep 16
Asia-Pacific gastric cancer market set to experience strong growth to $2.7 billion by 2022, says GBI Research

The Asia-Pacific (APAC) gastric cancer market is set to rise from $1.3 billion in 2015 to $2.7 billion by 2022, at a strong compound annual growth rate of 11.4%, according to business intelligence provider GBI Research.

Read post
14 Sep 16
Ophthalmology’s diverse pipeline could rejuvenate previously stagnant therapy area, says GBI Research

The ophthalmology market has experienced relatively little advancement in recent years and, with large unmet needs remaining in this area, there are strong opportunities for more products to enter the treatment space, according to business intelligence provider GBI Research.

Read post
31 Aug 16
Glioblastoma market set for strong innovation, with 120 first-in-class programs, says GBI Research

Glioblastoma, a particularly aggressive form of brain tumor, has a promising treatment pipeline, with 120 first-in-class programs acting on 86 first-in-class molecular targets, according to business intelligence provider GBI Research.

Read post
24 Aug 16
Diabetes and obesity therapeutics market will more than double to $163.2 billion by 2022, says GBI Research

The global market for diabetes mellitus and obesity is set to rise from $70.8 billion in 2015 to $163.2 billion by 2022, at a strong compound annual growth rate of 12.7%, according to business intelligence firm GBI Research.

Read post
22 Aug 16
Chronic pain treatment pipeline could yield innovative alternatives to opioids, says GBI Research

Although opioids continue to dominate the chronic pain market, adverse events associated with the drug such as the potential for abuse mean the treatment space is rife with unmet needs, which is encouraging pharmaceutical companies to explore innovative alternatives to opioids, according to business intelligence provider GBI Research.

Read post